FOS and polycystic ovary syndrome: Double-labeling immunofluorescence showed that the expression level of FOS protein in ovarian granulosa cells of the PCOS model group was reduced compared to that in the control group (P = 0.002), and BSTJF treatment significantly increased the expression level (P = 0.018).